Non-invasive assessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in diabetes

Diabetes and Vascular Disease Research

Volumn 10, Issue 2, 2013, Pages 123-134

  Djaberi, Roxana ^a   Schuijf, Joanne D ^a   De Koning, Eelco J ^a   Wijewickrama, D Champa ^a   Pereira, Alberto M ^a   Smit, Johannes W ^a   Kroft, Lucia J ^a   De Roos, Albert ^a   Bax, Jeroen J ^a   Rabelink, Ton J ^a   Jukema, J Wouter ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Einthoven Laboratory of Experimental Vascular Medicine   (Netherlands)

Author keywords

angiogenesis; coronary disease; diabetes mellitus; imaging; Microcirculation

Indexed keywords

ADULT; ARTICLE; CAPILLARY DENSITY; CARDIOVASCULAR PARAMETERS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMAGING; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; MICROSCOPE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; SIDESTREAM DARK FIELD IMAGING; VALIDATION STUDY;

ADULT; AGED; CALCINOSIS; CAPILLARIES; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIP; MALE; MICROCIRCULATION; MICROSCOPY; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84874100668     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164112446302     Document Type: Article

References (36)

1. American Diabetes Association. Diabetes Basics. Diabetes Statistics, http://www.diabetes.org/diabetes-statistics.jsp (2011, accessed 24 April 2011).
2. Raggi P, Bellasi A, Ratti C. Ischemia imaging and plaque imaging in diabetes: Complementary tools to improve cardiovascular risk management. Diabetes Care. 2005 ; 28: 2787-2794
3. Young LH, Wackers FJ, Chyun DA, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD study: A randomized controlled trial. JAMA. 2009 ; 301: 1547-1555
4. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med. 1984 ; 310: 356-360
5. Gall MA, Borch-Johnsen K, Hougaard P, et al. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes. 1995 ; 44: 1303-1309
6. Cheung N, Wang JJ, Klein R, et al. Diabetic retinopathy and the risk of coronary heart disease: The Atherosclerosis Risk in Communities Study. Diabetes Care. 2007 ; 30: 1742-1746
7. Soedamah-Muthu SS, Chaturvedi N, Witte DR, et al. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: The EURODIAB Prospective Complications Study (PCS). Diabetes Care. 2008 ; 31: 1360-1366
8. Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol. 2009 ; 53: S35 - S42
9. Moreno PR, Purushothaman KR, Sirol M, et al. Neovascularization in human atherosclerosis. Circulation. 2006 ; 113: 2245-2252
10. Groner W, Winkelman JW, Harris AG, et al. Orthogonal polarization spectral imaging: A new method for study of the microcirculation. Nat Med. 1999 ; 5: 1209-1212
11. De Backer D, Hollenberg S, Boerma C. How to evaluate the microcirculation: Report of a round table conference. et al ; 2007 ; 2007. R101.
12. Struijker-Boudier HA, Rosei AE, Bruneval P, et al. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J. 2007 ; 28: 2834-2840
13. De Backer D, Creteur J, Dubois MJ, et al. Microvascular alterations in patients with acute severe heart failure and cardiogenic shock. Am Heart J. 2004 ; 147: 91-99
14. Diabetes Care. 1997 1183 ; 20 :
15. Goedhart PT, Khalilzada M, Bezemer R, et al. Sidestream Dark Field (SDF) imaging: A novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express. 2007 ; 15: 15101-15114
16. Mathura KR, Vollebregt KC, Boer K, et al. Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation. J Appl Physiol. 2001 ; 91: 74-78
17. Boerma EC, Mathura KR, van der Voort PH, et al. Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: A prospective validation study. Crit Care. 2005 ; 9: R601 - R606
18. Sasongko MB, Wang JJ, Donaghue KC, et al. Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care. 2010 ; 33: 1331-1336
19. Nakagawa T, Kosugi T, Haneda M, et al. Abnormal angiogenesis in diabetic nephropathy. Diabetes. 2009 ; 58: 1471-1478
20. Osterby R, Nyberg G. New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabet Complications. 1987 ; 1: 122-127
21. Kanesaki Y, Suzuki D, Uehara G, et al. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis. 2005 ; 45: 288-294
22. Osterby R, Bangstad HJ, Nyberg G, et al. On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy. Virchows Arch. 2001 ; 438: 129-135
23. Wehner H, Nelischer G. Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats. Virchows Arch A Pathol Anat Histopathol. 1991 ; 419: 231-235
24. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: A systematic review. JAMA. 2007 ; 298: 902-916
25. Boone MI, Farber ME, Jovanovic-Peterson L, et al. Increased retinal vascular tortuosity in gestational diabetes mellitus. Ophthalmology. 1989 ; 96: 251-254
26. Factor SM, Minase T, Cho S, et al. Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy?. Am J Pathol. 1984 ; 116: 9-20
27. Saito F, Kawaguchi M, Izumida J, et al. Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of type 2 diabetes mellitus in OLETF rats. Diabetologia. 2003 ; 46: 1161-1169
28. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 ; 414: 813-820
29. Stehouwer CD, Lambert J, Donker AJ, et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 1997 ; 34: 55-68
30. Goldin A, Beckman JA, Schmidt AM, et al. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation. 2006 ; 114: 597-605
31. Stehouwer CD, Lambert J, Donker AJ, et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res. 1997 ; 34: 55-68
32. Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: The distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis. 2005 ; 183: 259-267
33. Miyamoto K, Khosrof S, Bursell SE, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol. 2000 ; 156: 1733-1739
34. Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int Suppl. 2000 ; 77: S113 - S119
35. Zeiher AM, Drexler H, Wollschläger H, et al. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation. 1991 ; 84: 1984-1992
36. Fleiner M, Kummer M, Mirlacher M, et al. Arterial neovascularization and inflammation in vulnerable patients: Early and late signs of symptomatic atherosclerosis. Circulation. 2004 ; 110: 2843-2850